Phase I, Open Label, Single Center Safety Study of [F-18]FLT
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This is a ten subject, phase 1 study. The purpose of the Phase 1 study is to demonstrate drug
safety in a target group of subjects with high grade brain cancer. This population represents
a potential clinical population that may benefit from this PET imaging tracer. The study will
also begin collection of baseline imaging data and allow us to gain information to improve
design and conduct of future trials.